Daichi Takizawa

1.1k citations
57 papers · 821 indexed · h-index 16

Daichi Takizawa

53 papers receiving 804 citations

Peers

Daichi Takizawa
Comparison fields: 5 of 77
  • Hepatology 408
  • Pharmacology 96
  • Epidemiology 270
  • Pathology and Forensic Medicine 91
  • Radiation 44
Replace Kiyokazu Hiwatashi with:
Kiyokazu Hiwatashi Japan
Feng Shi China
Tsutomu Minamino Japan
Zahra Ghiassi–Nejad United States
D. K. George Australia
Jianhua Wang China
Takeo Kimoto Japan
Kazuho Imanaka Japan
Anne Demols Belgium
Daichi Takizawa relative to Kiyokazu Hiwatashi Japan Kiyokazu Hiwatashi's profile →
Citations per field
00.5×6.3×
Kiyokazu Hiwatashi · 1×
Citations per year

Countries citing papers authored by Daichi Takizawa

Since Specialization
Citations

This map shows the geographic impact of Daichi Takizawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daichi Takizawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daichi Takizawa more than expected).

Fields of papers citing papers by Daichi Takizawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daichi Takizawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daichi Takizawa. The network helps show where Daichi Takizawa may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Daichi Takizawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daichi Takizawa Line = papers co-authored together Daichi Takizawa links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20241
2 20235
3 20212
4 20215
5 20212
6 20209
7 202014
8 201923
9 20195
10 201955
11 201816
12 201710
13 201740
14 201715
15 20161
16 20139
17
[Clinical evaluation of transcatheter arterial chemolipiodolization of miriplatin for multiple hepatocellular carcinoma].
20120
18 201016
19 201026
20 200915

About Daichi Takizawa

Daichi Takizawa is a scholar working on Hepatology, Epidemiology and Radiation, having authored 57 papers that have together received 821 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (18 papers), Liver Disease Diagnosis and Treatment (17 papers), Liver Disease and Transplantation (10 papers), Radiation Therapy and Dosimetry (8 papers), Hepatitis C virus research (8 papers), Advanced Radiotherapy Techniques (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers) and Hepatitis B Virus Studies (5 papers). The work is most often cited by research in Hepatology (408 citations), Pharmacology (96 citations) and Epidemiology (270 citations). Daichi Takizawa has collaborated with scholars based in Japan, United States and Taiwan. Frequent co-authors include Satoru Kakizaki, Yuichi Yamazaki, Ken Sato, Masatomo Mori, Hiroki Tojima, Hitoshi Takagi, Hirotaka Arai, Masahiko Negishi, Norio Horiguchi and Satoru Kakizaki. Their work appears in journals such as SHILAP Revista de lepidopterología, Gastroenterology and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026